News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,296 Results
Type
Article (14474)
Company Profile (101)
Press Release (263720)
Multimedia
Podcasts (71)
Webinars (14)
Section
Business (88408)
Career Advice (468)
Deals (15448)
Drug Delivery (82)
Drug Development (36800)
Employer Resources (50)
FDA (6415)
Job Trends (6249)
News (150975)
Policy (14150)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (454)
Accelerated approval (25)
ADA (10)
Adcomms (9)
Allergies (98)
Alliances (23332)
ALS (73)
Alzheimer's disease (523)
Antibody-drug conjugate (ADC) (165)
Approvals (6728)
Artificial intelligence (277)
ASCO (113)
Autoimmune disease (78)
Automation (21)
Bankruptcy (152)
Best Places to Work (4372)
BIO (19)
BIOSECURE Act (9)
Biosimilars (152)
Biotechnology (39)
Bladder cancer (51)
Brain cancer (40)
Breast cancer (210)
Cancer (1736)
Cardiovascular disease (201)
Career advice (422)
Career pathing (14)
CAR-T (66)
CDC (7)
Cell therapy (199)
Cervical cancer (20)
Clinical research (32630)
Collaboration (954)
Commercialization (1)
Company closure (1)
Compensation (402)
Complete response letters (47)
COVID-19 (786)
CRISPR (54)
C-suite (643)
Cystic fibrosis (62)
Data (2549)
Decentralized trials (1)
Denatured (19)
Depression (60)
Dermatology (16)
Diabetes (167)
Diagnostics (1455)
Digital health (16)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (165)
Drug pricing (122)
Drug shortages (15)
Duchenne muscular dystrophy (99)
Earnings (34233)
Editorial (24)
Employer branding (4)
Employer resources (46)
Events (39954)
Executive appointments (612)
FDA (7826)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (551)
Gene editing (86)
Generative AI (28)
Gene therapy (203)
GLP-1 (492)
Government (1432)
Grass and pollen (4)
Guidances (173)
Healthcare (3654)
Hematology (66)
HIV (17)
Huntington's disease (12)
IgA nephropathy (52)
Immunology and inflammation (85)
Immuno-oncology (30)
Indications (98)
Infectious disease (885)
Inflammatory bowel disease (88)
Inflation Reduction Act (7)
Influenza (29)
Intellectual property (138)
Interviews (60)
IPO (5931)
IRA (33)
Job creations (2060)
Job search strategy (375)
JPM (29)
Kidney cancer (12)
Labor market (38)
Layoffs (210)
Leadership (10)
Legal (3452)
Liver cancer (26)
Longevity (10)
Lung cancer (237)
Lymphoma (159)
Machine learning (16)
Management (17)
Manufacturing (570)
Marketing (1)
MASH (91)
Medical affairs (1)
Medical device (1317)
Medtech (1332)
Mergers & acquisitions (10041)
Metabolic disorders (569)
mRNA (63)
Multiple sclerosis (59)
NASH (15)
Neurodegenerative disease (111)
Neuropsychiatric disorders (48)
Neuroscience (1061)
Neurotech (1)
NextGen: Class of 2026 (1589)
Non-profit (609)
Now hiring (24)
Obesity (292)
Opinion (151)
Ovarian cancer (65)
Pain (136)
Pancreatic cancer (72)
Parkinson's disease (110)
Partnered (12)
Patents (279)
Patient recruitment (176)
Peanut (15)
People (30248)
Pharmaceutical (60)
Pharmacy benefit managers (19)
Phase 1 (8457)
Phase 2 (13782)
Phase 3 (12444)
Pipeline (3520)
Policy (149)
Postmarket research (1404)
Preclinical (3410)
Press Release (25)
Prostate cancer (114)
Psychedelics (22)
Radiopharmaceuticals (160)
Rare diseases (474)
Real estate (2670)
Recruiting (19)
Regulatory (11416)
Reports (16)
Research institute (583)
Resumes & cover letters (56)
Rett syndrome (11)
RNA editing (9)
RSV (25)
Schizophrenia (87)
Series A (114)
Series B (64)
Service/supplier (2)
Sickle cell disease (56)
Special edition (11)
Spinal muscular atrophy (85)
Sponsored (11)
Startups (1653)
State (2)
Stomach cancer (6)
Supply chain (64)
Tariffs (71)
The Weekly (50)
Vaccines (273)
Venture capital (40)
Weight loss (172)
Women's health (50)
Worklife (4)
Date
Today (32)
Last 7 days (153)
Last 30 days (858)
Last 365 days (10354)
2026 (5287)
2025 (10709)
2024 (12507)
2023 (14256)
2022 (19565)
2021 (20082)
2020 (19046)
2019 (14903)
2018 (11730)
2017 (13910)
2016 (13135)
2015 (15479)
2014 (12428)
2013 (10599)
2012 (11397)
2011 (11924)
2010 (10891)
Location
Africa (324)
Alabama (20)
Alaska (1)
Arizona (88)
Arkansas (4)
Asia (21269)
Australia (2744)
California (3947)
Canada (1793)
China (750)
Colorado (175)
Connecticut (156)
Delaware (169)
Europe (41687)
Florida (750)
Georgia (76)
Hawaii (1)
Idaho (11)
Illinois (459)
India (66)
Indiana (309)
Iowa (2)
Japan (352)
Kansas (84)
Kentucky (23)
Louisiana (7)
Maine (2)
Maryland (502)
Massachusetts (3191)
Michigan (55)
Minnesota (206)
Mississippi (1)
Missouri (39)
Montana (9)
Nebraska (8)
Nevada (19)
New Hampshire (9)
New Jersey (1757)
New Mexico (7)
New York (1132)
North Carolina (744)
North Dakota (2)
Northern California (1869)
Ohio (94)
Oklahoma (5)
Oregon (18)
Pennsylvania (858)
Puerto Rico (18)
Rhode Island (18)
South America (508)
South Carolina (11)
Southern California (1736)
Tennessee (67)
Texas (560)
United States (15661)
Utah (66)
Vermont (1)
Virginia (210)
Washington D.C. (42)
Washington State (290)
West Virginia (1)
Wisconsin (50)
Wyoming (1)
278,296 Results for "jcr pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
June 18, 2026
·
9 min read
Press Releases
JCR Pharmaceuticals to Present at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026 - May 28, 2026
May 28, 2026
·
8 min read
Press Releases
JCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
May 11, 2026
·
3 min read
Press Releases
JCR Pharmaceuticals’ Research Presentations at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
June 9, 2026
·
13 min read
Press Releases
JCR Pharmaceuticals to Present at the 22nd Annual WORLDSymposium™ 2026
January 28, 2026
·
8 min read
Press Releases
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising Central Nervous System Uptake at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
May 18, 2026
·
8 min read
Press Releases
JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
·
2 min read
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR Pharmaceuticals for use in up to five of Alexion’s gene therapies.
July 9, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
February 5, 2026
·
17 min read
Press Releases
Italfarmaco and JCR Pharmaceuticals Announce Commercialisation Agreement for Givinostat in Japan and Strategic Collaboration in Rare Disease
December 25, 2025
·
8 min read
1 of 27,830
Next
